These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20591200)
1. Mortality in Western Australian seniors with chronic respiratory diseases: a cohort study. Einarsdóttir K; Preen DB; Sanfilippo FM; Reeve R; Emery JD; Holman CD BMC Public Health; 2010 Jul; 10():385. PubMed ID: 20591200 [TBL] [Abstract][Full Text] [Related]
2. Regular primary care lowers hospitalisation risk and mortality in seniors with chronic respiratory diseases. Einarsdóttir K; Preen DB; Emery JD; Kelman C; Holman CD J Gen Intern Med; 2010 Aug; 25(8):766-73. PubMed ID: 20425147 [TBL] [Abstract][Full Text] [Related]
3. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy. Di Martino M; Agabiti N; Cascini S; Kirchmayer U; Bauleo L; Fusco D; Belleudi V; Pinnarelli L; Voci C; Patorno E; Pistelli R; Davoli M; COPD; 2016 Jun; 13(3):293-302. PubMed ID: 26514912 [TBL] [Abstract][Full Text] [Related]
4. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study. Wurst KE; Shukla A; Muellerova H; Davis KJ COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236 [TBL] [Abstract][Full Text] [Related]
5. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915 [TBL] [Abstract][Full Text] [Related]
6. Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease. Arfè A; Nicotra F; Cerveri I; de Marco R; Vaghi A; Merlino L; Corrao G COPD; 2016 Oct; 13(5):540-6. PubMed ID: 26934569 [TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids and mortality in COPD. Macie C; Wooldrage K; Manfreda J; Anthonisen NR Chest; 2006 Sep; 130(3):640-6. PubMed ID: 16963657 [TBL] [Abstract][Full Text] [Related]
8. Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome. Lim HS; Choi SM; Lee J; Park YS; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Lee CH Ann Allergy Asthma Immunol; 2014 Dec; 113(6):652-7. PubMed ID: 25280465 [TBL] [Abstract][Full Text] [Related]
9. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013. Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637 [TBL] [Abstract][Full Text] [Related]
10. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304 [TBL] [Abstract][Full Text] [Related]
11. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence. Schmier JK; Halpern MT; Jones ML Drugs Aging; 2005; 22(9):717-29. PubMed ID: 16156676 [TBL] [Abstract][Full Text] [Related]
12. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists. Mapel DW; Hurley JS; Roblin D; Roberts M; Davis KJ; Schreiner R; Frost FJ Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151 [TBL] [Abstract][Full Text] [Related]
13. Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients. Contoli M; Campo G; Pavasini R; Marchi I; Pauletti A; Balla C; Spanevello A; Ferrari R; Papi A Eur J Intern Med; 2018 Jan; 47():82-86. PubMed ID: 28821412 [TBL] [Abstract][Full Text] [Related]
14. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA Ann Pharmacother; 2017 Nov; 51(11):945-953. PubMed ID: 28677404 [TBL] [Abstract][Full Text] [Related]
15. Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma-COPD overlap: a systematic review and meta-analysis. Amegadzie JE; Gorgui J; Acheampong L; Gamble JM; Farrell J; Gao Z J Asthma; 2021 Mar; 58(3):344-359. PubMed ID: 31668101 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. Busch R; Han MK; Bowler RP; Dransfield MT; Wells JM; Regan EA; Hersh CP; BMC Pulm Med; 2016 Feb; 16():28. PubMed ID: 26861867 [TBL] [Abstract][Full Text] [Related]
17. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506 [TBL] [Abstract][Full Text] [Related]
18. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD. Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276 [TBL] [Abstract][Full Text] [Related]
19. Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach. Lin HW; Chung CL; Lin YS; Yu CM; Lee CN; Bien MY PLoS One; 2015; 10(7):e0130102. PubMed ID: 26158649 [TBL] [Abstract][Full Text] [Related]
20. The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach. Belleudi V; Di Martino M; Cascini S; Kirchmayer U; Pistelli R; Formoso G; Fusco D; Davoli M; Agabiti N; Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1295-1304. PubMed ID: 27396695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]